TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.

Robert Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.